Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cellular Oncology
Published in: Cellular Oncology 3/2014

01-06-2014 | ISCO 2014

The cancer genome: from structure to function

Author: Ad Geurts van Kessel

Published in: Cellular Oncology | Issue 3/2014

Login to get access

Abstract

The 2014 joint meeting of the International Society for Cellular Oncology (ISCO) and the European Workshop on Cytogenetics and Molecular Genetics of Solid Tumors (EWCMST), organized by Nick Gilbert, Juan Cigudosa and Bauke Ylstra, was held from 11 to 14 May in Malaga, Spain. Since the previous meeting in 2012, the ever increasing availability of new sequencing technologies has enabled the analysis of cancer genomes at an increasingly greater detail. In addition to structural changes in the genome (i.e., translocations, deletions, amplifications), frequent mutations in important regulatory genes have been found to occur, as also frequent alterations in a large number of epigenetic factors. The challenge now is to relate structural changes in cancer genomes to the underlying disease mechanisms and to reveal opportunities for the design of novel (targeted) therapies. During the meeting, various topics related to these challenges and opportunities were addressed, including those dealing with functional genomics, genome instability, biomarkers and diagnostics, cancer genetics and epigenomics. Special attention was paid to therapy-driven cancer evolution (keynote lecture) and relationships between DNA repair, cancer and ageing (Prof. Ploem lecture). Based on the information presented at the meeting, several aspects of the cancer genome and its functional implications are provided in this report.
Literature
1.
A. Geurts van Kessel, New insights and advancements in cellular oncology. Cell. Oncol. 35, 139–147 (2012)CrossRef
2.
F. Supek, B. Minana, J. Valcarcel, T. Gabaldon, B. Lehner, Synonymous mutations frequently act as driver mutations in human cancers. Cell 156, 1324–1335 (2014)PubMedCrossRef
3.
J.J. Gartner, S.C.J. Parker, T.D. Prickett, K. Dutton-Regester, M.L. Stitzel, J.C. Lin, S. Davis, V.L. Simhadri, S. Jhaf, N. Katagiri, V. Gotea, J.K. Teer, X. Wei, M.A. Morken, U.K. Bhanot, NISC Comparative Sequencing Program, G. Chen, L.L. Elnitski, M.A. Davies, J.E. Gershenwald, H. Carter, R. Karchin, W. Robinson, S. Robinson, S.A. Rosenberg, F.S. Collins, G. Parmigiani, A.A. Komar, C. Kimchi-Sarfaty, N.K. Hayward, E.H. Margulies, Y. Samuels, Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma. Proc. Natl. Acad. Sci. U. S. A. 110, 13481–13486 (2013)PubMedCentralPubMedCrossRef
4.
V.K. Hill, J.J. Gartner, Y. Samuels, A.M. Goldstein, The genetics of melanoma: recent advances. Ann. Rev. Gen. Hum. Genet. 14, 257–279 (2013)CrossRef
5.
6.
Z. Nie, G. Hu, G. Wei, K. Cui, A. Yamane, W. Resch, R. Wang, D.R. Green, L. Tessarollo, R. Casellas, K. Zhao, D. Levens, c-Myc Is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151, 68–79 (2012)PubMedCentralPubMedCrossRef
7.
C.Y. Lin, J. Loven, P.B. Rahl, R.M. Paranal, C.B. Burge, J.E. Bradner, T.I. Lee, R.A. Young, Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151, 56–67 (2012)PubMedCentralPubMedCrossRef
8.
9.
H. Clevers, E. Battle, Snapshot: the intestinal crypt. Cell 152, 1198.e1 (2013)CrossRef
10.
W.H. Liu, N. You, N. Zhang, H.T. Yan, T. Wang, Z. Huang, H.B. Liu, L.J. Tang, Interpretation of interlocking key issues of cancer stem cells in malignant solid tumors. Cell. Oncol. 35, 397–409 (2012)CrossRef
11.
M.D. Hale, J.D. Hayden, H.I. Grabsch, Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy reponse. Cell. Oncol. 36, 95–112 (2013)CrossRef
12.
M. Kraman, P.J. Bambrough, J.N. Arnold, E.W. Roberts, L. Magiera, J.O. Jones, A. Gopinathan, D.A. Tuveson, D.T. Fearon, Suppression of antitumor immunity by stromal cells expressing fibroblast activating protein-alpha. Science 330, 827–830 (2010)PubMedCrossRef
13.
A. Calon, E. Espinet, S. Palomo-Ponce, D.V.F. Tauriello, M. Iglesias, M. Virtudes Céspedes, M. Sevillano, C. Nadal, P. Jung, X.H.F. Zhang, D. Byrom, A. Riera, D. Rossell, R. Mangues, J. Massague, E. Sancho, E. Batlle, Dependency of colorectal cancer on a TGF-beta-driven programme in stromal cells for metastasis initiation. Cancer Cell 22, 571–584 (2012)PubMedCentralPubMedCrossRef
14.
A. Calona, D.V.F. Taurielloa, E. Batlle, TGF-beta in CAF-mediated tumor growth and metastasis. Sem. Cancer Biol. 25, 15–22 (2014)CrossRef
15.
N.A. Ajoub, A.D. Devaprasath, J.A. Bernal, A.R. Venkitaraman, HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response. Nature 453, 682–686 (2008)CrossRef
16.
M.J. Garnett, J. Mansfeld, C. Godwin, T. Matsusaka, J. Wu, P. Russell, J. Pines, A.R. Venkitaraman, UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit. Nature Cell Biol. 11, 1363–1369 (2009)PubMedCentralPubMedCrossRef
17.
A.D. Jeyasekharan, Y. Liu, H. Hattori, V. Pisupati, A.B. Jonsdottir, E. Rajendra, M. Lee, E. Sundaramoorthy, S. Schlachter, C. Kaminski, Y. Rosenfeld, K. Sato, J. Savill, N. Ayoub, A.R. Venkitaraman, A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization. Nature Struct. Mol. Biol. 20, 1191–1198 (2013)CrossRef
18.
19.
E. Yiannakopoulou, Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications. Cell. Oncol. 37, 1–8 (2014)CrossRef
20.
A.R. Venkitaraman, Cancer suppression by the chromosome custodians, BRCA1 and BRCA2. Science 343, 1470–1475 (2014)PubMedCrossRef
21.
S. Remeseiro, A. Cuadrado, A. Losada, Cohesin in development and disease. Development 140, 3715–3718 (2013)PubMedCrossRef
22.
D.A. Solomon, T. Kim, L.A. Diaz-Martinez, J. Fair, A.G. Elkahloun, B.T. Harris, J.A. Toretsky, S.A. Rosenberg, N. Shukla, M. Ladanyi, Y. Samuels, C.D. James, H. Yu, J.S. Kim, T. Waldman, Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 333, 1039–1043 (2011)PubMedCentralPubMedCrossRef
23.
S. Remeseiro, A. Cuadrado, G. Gomez-Lopez, D.G. Pisano, A. Losado, A unique role of cohesion-SA1 in gene regulation and development. EMBO J. 31, 2090–2102 (2012)PubMedCentralPubMedCrossRef
24.
J.S. Welch, T.J. Ley, D. Link, C.A. Miller, D.E. Larson, D.C. Koboldt, L.D. Wartman, T. Lamprecht, F. Liu, J. Xia, C. Kandoth, R.S. Fulton, M.D. McLellan, D.J. Dooling, J.W. Wallis, K. Chen, C.C. Harris, H.K. Schmidt, J.M. Kalicki-Veizer, C. Lu, Q. Zhang, L. Lin, M.D. O’Laughlin, J.F. McMichael, K.D. Delehaunty, L.A. Fulton, V.J. Magrini, S.D. McGrath, R.T. Demeter, T.L. Vickery, J. Hundal, L.L. Cook, G.W. Swift, J.P. Reed, P.A. Alldredge, T.N. Wylie, J.R. Walker, M.A. Watson, S.E. Heath, W.D. Shannon, N. Varghese, R. Nagarajan, J.E. Payton, J.D. Baty, S. Kulkarni, J.M. Klco, M.H. Tomasson, P. Westervelt, M.J. Walter, T.A. Graubert, J.F. DiPersio, L. Ding, E.R. Mardis, R.K. Wilson, The origin and evolution of mutations in acute myeloid leukemia. Cell 150, 264–275 (2012)PubMedCentralPubMedCrossRef
25.
D.W. Schoppy, R.L. Ragland, O. Gilad, N. Shastri, A.A. Peters, M. Murga, O. Fernandez-Capetillo, J.A. Diehl, E.J. Brown, Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR. J. Clin. Invest. 122, 242–252 (2012)
26.
A. Alentorn, H.F. van Thuijl, Y. Marie, H. Alshehhi, C. Carpentier, B. Boisselier, F. Laigle-Donadey, K. Mokhtari, I. Scheinin, P. Wesseling, B. Ylstra, L. Capelle, K. Hoang-Xuan, M. Sanson, J.Y. Delattre, J.C. Reijneveld, A. Idbaih, Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas. Neuro. Oncol. 16, 400–408 (2014)PubMedCrossRef
27.
28.
P. Bus, P.D. Siersema, J.W.P.M. van Baal, Cell culture models for studying the development of Barrett’s esophagus: a systematic review. Cell. Oncol. 35, 149–161 (2012)CrossRef
29.
A.M. Dulak, P. Stojanov, S. Peng, M.S. Lawrence, C. Fox, C. Stewart, S. Bandla, Y. Imamura, S.E. Schumacher, E. Shefler, A. McKenna, S.L. Carter, K. Cibulskis, A. Sivachenko, G. Saksena, D. Voet, A.H. Ramos, D. Auclair, K. Thompson, C. Sougnez, R.C. Onofrio, C. Guiducci, R. Beroukhim, Z. Zhou, L. Lin, J. Lin, R. Reddy, A. Chang, R. Landrenau, A. Pennathur, S. Ogino, J.D. Luketich, T.R. Golub, S.B. Gabriel, E.S. Lander, D.G. Beer, T.E. Godfrey, G. Getz, A.J. Bass, Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nature Genet. 45, 478–486 (2013)PubMedCrossRef
30.
P.L. Bedard, A.R. Hansen, M.J. Ratain, L.L. Siu, Tumour heterogeneity in the clinic. Nature 501, 355–364 (2013)PubMedCrossRef
31.
E. Waanders, B. Scheijen, S. van Reijmersdal, T. van der Meer, L. van Emst, Y. Kroeze, E. Sonneveld, P.M. Hoogerbrugge, A. Geurts van Kessel, F.N. van Leeuwen, R.P. Kuiper, The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution. PloS Genet. 8, e1002533 (2012)
32.
P. Ulivi, R. Silvestrini, Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer. Cell. Oncol. 36, 439–448 (2013)CrossRef
33.
L.H.A. Broersen, G.W. van Pelt, R.A.E.M. Tollenaar, W.E. Mesker, Clinical application of circulating tumor cells in breast cancer. Cell. Oncol. 37, 9–15 (2014)CrossRef
34.
F.X. Real, P.C. Boutros, N. Malats, Next-generation sequencing of urologic cancers: next is now. Eur. Urol. 66, 4–7 (2014)PubMedCrossRef
35.
The Cancer Genome Atlas Research Network, Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315–322 (2014)CrossRef
36.
N. Ganguly, Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value. Cell. Oncol. 35, 67–76 (2012)CrossRef
37.
G. Iye, A.J. Hanrahan, M.I. Milowsky, H. Al-Ahmadie, S.N. Scott, M. Janakiraman, M. Pirun, C. Sander, N.D. Socci, I. Ostrovnaya, A. Viale, A. Heguy, L. Peng, T.A. Chan, B. Bochner, D.F. Bajorin, M.F. Berger, B.S. Taylor, D.B. Solit, Genome sequencing identifies a basis for everolimus sensitivity. Science 338, 221 (2012)CrossRef
38.
M.D. Jones, E.K. Colvin, A.M. Nagrial, E.S. Humphrey, A. Chou, V.T. Chin, L.A. Chantrill, A. Mawson, J.S. Samra, J.G. Kench, J.A. Lovell, R.J. Daly, N.D. Merrett, C. Toon, K. Epari, N.Q. Nguyen, A. Barbour, N. Zeps, Australian Pancreatic Cancer Genome Initiative, N. Kakkar, F. Zhao, Y.Q. Wu, M. Wang, D.M. Muzny, W.E. Fisher, F.C. Brunicardi, S.E. Hodges, J.G. Reid, J. Drummond, K. Chang, Y. Han, L.R. Lewis, H. Dinh, C.J. Buhay, T. Beck, L. Timms, M. Sam, K. Begley, A. Brown, D. Pai, A. Panchal, N. Buchner, R. De Borja, R.E. Denroche, C.K. YungK, S. Serra, N. Onetto, D. Mukhopadhyay, M.S. Tsao, P.A. Shaw, G.M. Petersen, S. Gallinger, R.H. Hruban, A. Maitra, C.A. Iacobuzio-Donahue, R.D. Schulick, C.L. Wolfgang, R.A. Morgan, R.T. Lawlor, P. Capelli, V. Corbo, M. Scardoni, G. Tortora, M.A. Tempero, K.M. Mann, N.A. Jenkins, P.A. Perez-Mancera, D.J. Adams, D.A. Largaespada, L.F. Wessels, A.G. Rust, L.D. Stein, D.A. Tuveson, N.G. Copeland, E.A. Musgrove, A. Scarpa, J.R. Eshleman, T.J. Hudson, R.L. Sutherland, D.A. Wheeler, J.V. Pearson, J.D. McPherson, R.A. Gibbs, S.M. Grimmond, Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399–405 (2012)PubMedCentralPubMedCrossRef
39.
D.K. Chang, S.M. Grimmond, A.V. Biankin, Pancreatic cancer genomics. Curr. Opin. Genet. Dev. 24, 74–81 (2014)PubMedCrossRef
40.
T. Rausch, D.T. Jones, M. Zapatka, A.M. Stütz, T. Zichner, J. Weischenfeldt, N. Jäger, M. Remke, D. Shih, P.A. Northcott, E. Pfaff, J. Tica, Q. Wang, L. Massimi, H. Witt, S. Bender, S. Pleier, H. Cin, C. Hawkins, C. Beck, A. von Deimling, V. Hans, B. Brors, R. Eils, W. Scheurlen, J. Blake, V. Benes, A.E. Kulozik, O. Witt, D. Martin, C. Zhang, R. Porat, D.M. Merino, J. Wasserman, N. Jabado, A. Fontebasso, L. Bullinger, F.G. Rücker, K. Döhner, H. Döhner, J. Koster, J.J. Molenaar, R. Versteeg, M. Kool, U. Tabori, D. Malkin, A. Korshunov, M.D. Taylor, P. Lichter, S.M. Pfister, J.O. Korbel, Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148, 59–71 (2012)PubMedCentralPubMedCrossRef
41.
J. Weischenfeldt, R. Simon, L. Feuerbach, K. Schlangen, D. Weichenhan, S. Minner, D. Wuttig, H.J. Warnatz, H. Stehr, T. Rausch, N. Jäger, L. Gu, O. Bogatyrova, A.M. Stütz, R. Claus, J. Eils, R. Eils, C. Gerhäuser, P.H. Huang, B. Hutter, R. Kabbe, C. Lawerenz, S. Radomski, C.C. Bartholomae, M. Fälth, S. Gade, M. Schmidt, N. Amschler, T. Haß, R. Galal, J. Gjoni, R. Kuner, C. Baer, S. Masser, C. von Kalle, T. Zichner, V. Benes, B. Raeder, M. Mader, V. Amstislavskiy, M. Avci, H. Lehrach, D. Parkhomchuk, M. Sultan, L. Burkhardt, M. Graefen, H. Huland, M. Kluth, A. Krohn, H. Sirma, L. Stumm, S. Steurer, K. Grupp, H. Sültmann, G. Sauter, C. Plass, B. Brors, M.L. Yaspo, J.O. Korbel, T.T. Schlomm, Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell 23, 159–170 (2013)PubMedCrossRef
42.
S. Babashah, M. Sadeghizadeh, M.R. Tavirani, S. Farivar, M. Soleimani, Aberrant microRNA expression and its implications in the pathogenesis of leukemias. Cell. Oncol. 35, 317–334 (2012)CrossRef
43.
M.F. Arteaga, J.H. Mikesch, J. Qiu, J. Christensen, K. Helin, S.C. Kogan, S. Dong, C.W.E. So, The histone demethylase PHF8 governs retinoic acid response in acute promyelocytic leukemia. Cancer Cell 23, 376–389 (2013)PubMedCrossRef
44.
T.K. Fung, C.W.E. So, Overcoming treatment resistance in acute promyelocytic leukemia and beyond. Oncotarget 4, 1128–1129 (2013)PubMedCentralPubMed
45.
M.A. Dawson, R.K. Prinjha, A. Dittman, G. Giotopoulos, M. Bantscheff, W.I. Chan, S.C. Robson, C.W. Chung, C. Hopf, M.M. Savitski, C. Huthmacher, E. Gudgin, D. Lugo, S. Beinke, T.D. Chapman, E.J. Roberts, P.E. Soden, K.R. Auger, O. Mirguet, K. Doehner, R. Delwel, A.K. Burnett, P. Jeffrey, G. Drewes, K. Lee, B.J.P. Huntly, T. Kouzarides, Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478, 529–533 (2013)CrossRef
46.
M.A. Dawson, E.J. Gudgin, S.J. Horton, G. Giotopoulos, E. Meduri, S. Robson, E. Cannizzaro, H. Osaki, M. Wiese, S. Putwain, C.Y. Fong, C. Grove, J. Craig, A. Dittmann, D. Lugo, P. Jeffrey, G. Drewes, K. Lee, L. Bullinger, R.K. Prinjha, T. Kouzarides, G.S. Vassiliou, B.J.P. Huntly, Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia. Leukemia 28, 311–320 (2014)PubMedCentralPubMedCrossRef
47.
D. Sturm, S. Bender, D.T.W. Jones, P. Lichter, J. Grill, O. Becher, C. Hawkins, J. Majewski, C. Jones, J.F. Costello, A. Iavarone, K. Aldape, C.W. Brennan, N. Jabado, S.M. Pfister, Paediatric and adult glioblastoma: multiform (epi) genomic culprits emerge. Nature Rev. Cancer 14, 92–107 (2014)CrossRef
48.
A.M. Fontebasso, S. Papillon-Cavanagh, J. Schwartzentruber, H. Nikbakht, N. Gerges, P.O. Fiset, D. Bechet, D. Faury, N. De Jay, L.A. Ramkissoon, A. Corcoran, D.T.W. Jones, D. Sturm, P. Johann, T. Tomita, S. Goldman, M. Nagib, A. Bendel, L. Goumnerova, D.C. Bowers, J.R. Leonard, J.B. Rubin, T. Alden, S. Browd, J.R. Geyer, S. Leary, G. Jallo, K. Cohen, N. Gupta, M.D. Prados, A.S. Carret, B. Ellezam, L. Crevier, A. Klekner, L. Bognar, P. Hauser, M. Garami, J. Myseros, Z. Dong, P.M. Siegel, H. Malkin, A.H. Ligon, S. Albrecht, S.M. Pfister, K.L. Ligon, J. Majewski, N. Jabado, M.W. Kieran, Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nature Genet. 46, 462–466 (2014)PubMedCrossRef
49.
B.E. Johnson, T. Mazor, C. Hong, M. Barnes, K. Aihara, C.Y. McLean, S.D. Fouse, S. Yamamoto, H. Ueda, K. Tatsuno, S. Asthana, L.E. Jalbert, S.J. Nelson, A.W. Bollen, W.C. Gustafson, E. Charron, W.A. Weiss, I.V. Smirnov, J.S. Song, A.B. Olshen, S. Cha, Y. Zhao, R.A. Moore, A.J. Mungall, S.J.M. Jones, M. Hirst, M.A. Marra, N. Saito, H. Aburatani, A. Mukasa, M.S. Berger, S.M. Chang, B.S. Taylor, J.F. Costello, Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343, 189–193 (2014)PubMedCentralPubMedCrossRef
50.
M.J. Jonker, J.P. Melis, J.R.V. Kuiper, T.V. van der Hoeven, P.F. Wackers, J. Robinson, G.T. van der Horst, M.E. Dollé, J. Vijg, T.M. Breit, J.H.J. Hoeijmakers, H. van Steeg, Life spanning murine gene expression profiles in relation to chronological and pathological aging in multiple organs. Aging Cell. 12, 901–909 (2013)PubMedCrossRef
51.
H. Lans, J.M. Lindvall, K. Thijssen, A.E. Karambelas, D. Cupac, Ø. Fensgard, G. Jansen, J.H.J. Hoeijmakers, H. Nilsen, W. Vermeulen, DNA damage leads to progressive replicative decline but extends the life span of long-lived mutant animals. Cell Death Diff. 20, 1709–1718 (2013)CrossRef
52.
S. Gravina, M.E.T. Dolle’, T. Wang, H. van Steeg, P. Hasty, J. Hoeijmakers, J. Vijg, High preservation of CpG cytosine methylation patterns at imprinted gene loci in liver and brain of aged mice. PLoS One 8, e73496 (2013)PubMedCentralPubMedCrossRef
Metadata
Title
The cancer genome: from structure to function
Author
Ad Geurts van Kessel
Publication date
01-06-2014
Publisher
Springer Netherlands
Published in
Cellular Oncology / Issue 3/2014
Print ISSN: 2211-3428
Electronic ISSN: 2211-3436
DOI
https://doi.org/10.1007/s13402-014-0177-5

Other articles of this Issue 3/2014

Cellular Oncology 3/2014 Go to the issue

Original Paper

Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status

Original Paper

Automated classification of oral premalignant lesions using image cytometry and Random Forests-based algorithms

Original Paper

Expression of H1.5 and PLZF in granulosa cell tumors and normal ovarian tissues: a short report

Review

Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents - implications for cancer treatment and chemoprevention

Original Paper

Retinoblastoma (RB1) pocket domain mutations and promoter hyper-methylation in head and neck cancer

Original Paper

Identification of GPM6A and GPM6B as potential new human lymphoid leukemia-associated oncogenes
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits